Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Novartis’s Cosentyx: Europe’s First IL-17A Inhibitor for Some Uses
Novartis’s Cosentyx: Europe’s First IL-17A Inhibitor for Some Uses
Novartis’s Cosentyx: Europe’s First IL-17A Inhibitor for Some Uses
Submitted by
admin
on November 29, 2015 - 12:27pm
Source:
Yahoo/Market Realist
News Tags:
Novartis
Cosentyx
Europe
ankylosing spondylitis
psoriatic arthritis
Headline:
Novartis’s Cosentyx: Europe’s First IL-17A Inhibitor for Some Uses
Do Not Allow Advertisers to Use My Personal information
